Indeed, more recently, we have identified the complex formed by GADD45β and the JNK kinase, MKK7, as a functionally critical survival module downstream of NF-κB and novel therapeutic target in multiple myeloma [194,198,200,201,202,203]. This evidence concerns the gene NFKB1 and plasma cell myeloma.